Predictors of Mononuclear Cell Yield in Patients Undergoing Autologous Mononuclear Stem Cell Therapy in Non-haemopoietic Degenerative Disorders
- 29 Downloads
Cellular therapy outcomes are influenced by cellular composition of the product. We analyzed the cellular profiles (TNC, MNC and CD34+ cells) of patients receiving mononuclear cell therapy in terms of age, gender, BMI, pre-harvest haematological counts and clinical conditions. Cellular profiles of 262 patients were analyzed in terms of age (age < 40 year, age 41–60 year and age > 60 year), gender, BMI (BMI < 22 kg/m2, BMI 22–25 kg/m2 and BMI > 25 kg/m2), pre-harvest haematological profile and clinical conditions (chronic disorders, group A, acute vascular group B and traumatic events, group C). A steady decline was observed in TNC and MNC counts with increasing age and BMI. In clinical conditions, group C showed a highest cellular yield followed by group A and group B respectively. Amongst the three age groups, group I (age < 40 year) showed a better cellular profiles than group II (age 41–60 year) and group III (age > 60 year). Patients with Higher TLC (>7000/μl) and platelet count (>200 × 103/μl) yielded better cellular profile in the harvest. Patient age, BMI, haematological counts and clinical condition significantly affect the bone marrow cellular profile.
KeywordsAutologous bone marrow mononuclear cell therapy Bone marrow cellular profiles Advanced medicinal therapeutic products
- 4.Cottler-Fox M (1992) Bone marrow collection techniques. In: Areman E, Deeg H, Sacher R (eds) Bone marrow and stem cell processing: a manual of current techniques. Davis, PhiladelphiaGoogle Scholar
- 6.Gratama JW, Keeney M, Sutherland DR (1999) Enumeration of hematopoietic stem cell and progenitor cells. Curr Protoc Cytom 6:6.4.1–6.4.22Google Scholar
- 12.Page KM, Zhang L, Mendizabal A et al (2011) Total colony forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants. Biol Blood Marrow Transpl 17:1362–1374CrossRefGoogle Scholar